On TikTok, Reddit, and some telehealth websites, microdosing glucagon-like peptide-1 (GLP-1) receptor agonist medications is pitched as a gentler, more flexible way to use drugs such as the GLP-1 agonist semaglutide (Ozempic, Wegovy), the dual GIP/GLP-1 agonist tirzepatide (Mounjaro, Zepbound), and oral nonpeptide GLP-1 receptor agonist orforglipron (Foundayo)
Its easy to assume that a medication like retatrutide is automatically the strongest option because it targets three receptors instead of one or two
Semaglutide and Tirzepatide Semaglutide is primarily a GLP-1 receptor agonist Tirzepatide targets GLP-1 and GIP receptors Retatrutide targets GLP-1, GIP, and glucagon receptor pathways Because retatrutide activates additional metabolic receptors, some studies suggest that retatrutide may deliver greater weight loss compared with semaglutide and tirzepatide
This program provides access to compounded semaglutide through partnerships with trusted, state-licensed compounding pharmacies, known for its role in promoting personalized care and consistent quality
